Drugs & Medical Devices
Get ready for the next wave of pharmaceutical litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.
SEARCH THE ARCHIVES
Issue #9, September 2002
A federal judge denied certification of a proposed class of individuals who seek compensatory and punitive damages as result of their ingestion of Rezulin and a subclass of asymptomatic Rezulin users who seek the establishment of a medical monitoring pro
Plaintiffs involved in six separate PPA products liability cases were denied class certification for the establishment of two nationwide subclasses designed for consumers asserting economic injury claims, a federal judge ruled.
Plaintiffs Claim Manufacturer's Did Not Provide Scientific Evidence to Justify Motion for Reconsideration
Attorneys for the plaintiffs involved in a class action against the manufacturers of Paxil argue that GlaxoSmithKline's motion for reconsideration is not justified because it does not contain any new scientific evidence from the FDA that proves the drug i
A plaintiffs' motion to administratively close and stay individual federal Baycol cases pending final resolution of consolidated pretrial proceedings was denied by a federal judge who ruled that the plaintiffs failed to prove that the case would be subje
A lower court's decision to grant a defendants' motion to dismiss on grounds of forum non conveniens was overturned when the Pa. Superior Court ruled that the court incorrectly assumed the issues of the plaintiff's wrongful death case.
State Judge Grants Class Certification to Individuals Who Suffered Oxycontin Addiction and Withdrawal
A lawsuit filed on behalf of Ohio residents who suffered from addiction and withdrawal symptoms associated with the prescription painkiller Oxycontin has been granted class certification by a state judge.
A putative class action filed by the parents and guardians of children who were allegedly injured as the result Pfizer's experimental administration of Trovan is better suited for litigation in Nigeria, a federal judge ruled.
The manufacturers of the weight loss drug Meridia filed a notice to remove a products liability case to federal court claiming that a Louisiana health clinic was fraudulently joined to defeat diversity jurisdiction.
Three Florida women filed a statewide class action against Metabolife International, Inc., claiming that the supplement manufacturer failed to adequately warn consumers and physicians regarding the potential health hazards associated with Metabolife 356.